Ovarian cancer endpoints workshop

Executive Summary

FDA and the American Society for Clinical Oncology, in conjunction with FDA's Oncologic Drugs Advisory Committee, will hold a public workshop on ovarian cancer endpoints April 26 at the Marriott Hotel in North Bethesda, Md. FDA plans to issue a guidance document from the workshop findings. The agency has previously held meetings on lung, colorectal, prostate and brain cancer endpoints (1"The Pink Sheet" Feb. 6, 2006, p. 15). [Editor's note: To 2watch a webcastor order a video/DVD of this or any other meeting, visit FDAAdvisoryCommittee.com.]...